PRPF31
protein-codingpre-mRNA processing factor 31, the group of U4/U6 small nuclear ribonucleoprotein
Gene summary
This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.[provided by RefSeq, Jan 2009]
- RP11
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019200
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0800395
Submitter: ClinGen
*PRPF31* was first reported in relation to an inherited retinal dystrophy, described as autosomal dominant retinitis pigmentosa (adRP), in 2001 (Vithana et al., PMID: 11545739). To account for a spectrum of retinal phenotypes that may be caused by variants in this gene, and in accordance with the ClinGen Lumping and Splitting guidelines, the disease entity used for this curation is PRPF31-related retinopathy. This condition is characterized by night blindness (onset in teens), progressive visual loss, and blindness (onset in 30s). Ten variants (missense, in-frame indel, nonsense, frameshift, complex rearrangement) that have been reported in 10 probands in 06 publications (PMIDs: 11545739, 12714658, 12923864, 23288994, 29375987, 20939871) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. Interestingly, incomplete penetrance has been frequently observed in families with *PRPF31* pathogenic variants. There are over 200 *PRPF31* pathogenic and likely pathogenic variants listed on ClinVar (07/05/2022). The mechanism of pathogenicity is reported to be LOF. This gene-disease relationship is also supported by functional studies in patient derived organoids and retinal pigment epithelium, and *Prpf31+/-* mouse (PMIDs: 30315276, 20811066). In summary, *PRPF31* is definitively associated with PRPF31-releated retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This clinical validity classification was approved by the ClinGen Retina GCEP on July 7, 2022 (SOP v9).
Inheritance Pattern: AD
Disease ID:MONDO:0010828
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0010828
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0010828
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0010828
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRPF31 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015629.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 134 | 6 | 152 | ||
| missense | 4 | 18 | 203 | 13 | 238 | |
| nonsense | 38 | 23 | 61 | |||
| start loss | 3 | 2 | 5 | |||
| frameshift | 81 | 64 | 2 | 147 | ||
| splice donor/acceptor (+/-2bp) | 35 | 40 | 6 | 81 | ||
| Total | 161 | 147 | 223 | 147 | 6 | 684 |
Highest pathogenic variant AF is 0.00002479055
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056444.3 | 13 | MANE Select | |
| Ensembl | ENSP00000324122.4 | 13 | MANE Select | |
| Ensembl | ENSP00000375635.1 | 13 | Standard | |
| Ensembl | ENSP00000375635.1 | 13 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| prpf31 | Danio rerio | Structure: photoreceptor cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Spliceosome - Homo sapiens (human)
- Metabolism of RNA
- mRNA Splicing - Major Pathway
- mRNA Splicing
- Processing of Capped Intron-Containing Pre-mRNA
Biological Process
- spliceosomal tri-snRNP complex assembly
- mRNA splicing, via spliceosome
- snoRNA localization
- ribonucleoprotein complex localization
Molecular Function
- RNA binding
- protein binding
- U4 snRNA binding
- U4atac snRNA binding
- ribonucleoprotein complex binding
Cellular Component
- nucleus
- nucleoplasm
- U2-type spliceosomal complex
- U4 snRNP
- U4atac snRNP
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000321030
- Coding exons
- 13
- Length
- 16304
- Individuals with no LoFs
- 125703
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 125704
- p
- 0.00000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.05 | 164 | 317 | 0.518 | 0.0000231 | 3227 |
| Missense (PolyPhen) | 58 | 133.09 | 0.43578 | 1221 | ||
| Synonymous | -0.402 | 143 | 137 | 1.04 | 0.0000112 | 971 |
| Loss of Function | 4.14 | 3 | 25.6 | 0.117 | 0.00000121 | 312 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11867543, PubMed:28781166). Required for the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed:11867543). {ECO:0000269|PubMed:11867543, ECO:0000269|PubMed:28781166}.;
- Disease
- DISEASE: Retinitis pigmentosa 11 (RP11) [MIM:600138]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:11545739, ECO:0000269|PubMed:12444105, ECO:0000269|PubMed:12923864, ECO:0000269|PubMed:17412961, ECO:0000269|PubMed:8808602}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.315
Intolerance Scores
- LoFtool
- 0.170
- RVIS EVS
- -1.09
- RVIS percentile EVS
- 7.05
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.993
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |